NJ State Employees Deferred Compensation Plan’s Clovis Oncology, Inc. CLVS Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,000	Closed	-$15K	–	488
2022 Q3	$15K	Hold	13,000	–	–	﹤0.01%	475
2022 Q2	$23K	Hold	13,000	–	–	﹤0.01%	473
2022 Q1	$26K	Hold	13,000	–	–	﹤0.01%	497
2021 Q4	$35K	Hold	13,000	–	–	﹤0.01%	500
2021 Q3	$58K	Hold	13,000	–	–	0.01%	499
2021 Q2	$75K	Hold	13,000	–	–	0.01%	511
2021 Q1	$91K	Hold	13,000	–	–	0.01%	506
2020 Q4	$62K	Hold	13,000	–	–	0.01%	497
2020 Q3	$76K	Hold	13,000	–	–	0.01%	469
2020 Q2	$88K	Hold	13,000	–	–	0.02%	474
2020 Q1	$83K	Hold	13,000	–	–	0.02%	447
2019 Q4	$136K	Hold	13,000	–	–	0.02%	500
2019 Q3	$51K	Hold	13,000	–	–	0.01%	528
2019 Q2	$193K	Hold	13,000	–	–	0.03%	507
2019 Q1	$323K	Sell	13,000 -1,000	-7%	-$25.1K	0.06%	411
2018 Q4	$251K	Hold	14,000	–	–	0.05%	418
2018 Q3	$411K	Buy	14,000 +1,000	+8%	+$38.7K	0.07%	373
2018 Q2	$591K	Buy	13,000 +2,000	+18%	+$97.3K	0.11%	264
2018 Q1	$581K	Buy	11,000 +2,000	+22%	+$117K	0.1%	277
2017 Q4	$612K	Hold	9,000	–	–	0.11%	277
2017 Q3	$742K	Buy	+9,000	New	+$713K	0.13%	232

Other funds holding CLVS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's CLVS Position: Q4 2022 in Review

NJ State Employees Deferred Compensation Plan sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 13,000 shares — an estimated $15K sold.

NJ State Employees Deferred Compensation Plan first reported a position in CLVS in Q3 2017 and held it in 21 quarters. The position peaked at $742K in Q3 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

NJ State Employees Deferred Compensation Plan reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 13,000 Clovis Oncology, Inc. shares in Q4 2022, an estimated $15K.
NJ State Employees Deferred Compensation Plan first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 21 quarters.
NJ State Employees Deferred Compensation Plan's Clovis Oncology, Inc. position peaked at $742K in Q3 2017.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.